FDA: First Treatment Approved Specifically for Postpartum Depression

FDA: First Treatment Approved Specifically for Postpartum Depression

Zulresso administered by IV infusion over 60-hour period; patients must be monitored during infusion

2019-03-29T09:49:50+00:00

Leave A Comment